Head-to-head · WeighScore
HealthOn vs PepHaūs
By GLP-1 ScorecardUpdated
Score comparison
PepHaūs has the higher recorded score — 82.7/100 to 54.5/100.
PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compare monthly billing with prepaid commitments, then confirm renewal pricing and supply.
Before you choose
Before comparing the headline prices, the HealthOn review and the PepHaūs review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, HealthOn vs Piper and HealthRX vs PepHaūs compare each of them with another graded program, and the list of alternatives to HealthOn ranks the programs closest to HealthOn on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | HealthOn | PepHaūs |
|---|---|---|
| WeighScore | 54.5/100 | 82.7/100 |
| Grade | C | B− |
| Site position | #485 | #25 |
| Semaglutide | $189/mo (starting dose, 12-month plan, compounded) | $169 monthly; prepaid plans available (advertised) |
| Tirzepatide | $290/mo (starting dose, 12-month plan, compounded) | $239 monthly; prepaid plans available (advertised) |
| Coverage | Coverage not published | Claims all 50 states plus DC; treatment eligibility requires confirmation |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
FDAWarning letter issued to Healthon Inc. dba Healthon in September 2025. See the FDA warning-letter database.
Strengths
- Both compounded semaglutide and tirzepatide available
- Weight-loss pricing starts at $189/mo for compounded semaglutide
What to consider
- No visible LegitScript certification or PCAB accreditation
- State availability not publicly disclosed
- Lowest advertised prices require a 12-month plan commitment
- FDA issued Healthon Inc. dba Healthon a warning letter in September 2025; the letter is public in FDA's warning-letter database
Strengths
- Publishes monthly and prepaid plan amounts
- Names provider and pharmacy partners
What to consider
- Price-lock wording needs reconciling with renewal terms
- Actual supply and longer-plan shipments remain unverified
- Independent license and certification status remain unverified
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.